Phase 1 Study of SL-325 in Healthy Volunteers

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This first-in-human study is a randomized, double-blind, placebo-controlled, single-ascending dose and multiple-ascending dose study of SL-325 in healthy volunteers.
Epistemonikos ID: dfb261013955458fd44b13e4ec80495b97f6324b
First added on: Sep 06, 2025